Supernus Pharmaceuticals reported $283.45M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Adamas Pharmaceuticals ADMS:US 21.82M 7.35M
Aerie Pharmaceuticals AERI:US $ 108.09M 14.72M
Ani Pharmaceuticals ANIP:US $ 89.45M 6.69M
Aphria Inc APH:CN C$ 216.99M 75.99M
Aurora Cannabis Inc ACB:CN 131.71M 18.12M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Canopy Growth Corp WEED:CN C$ 256.13M 28.2M
Cara Therapeutics CARA:US $ 15.17M 1.35M
Corcept Therapeutics CORT:US $ 45.4M 4.8M
Eisai 4523:JP Y 277934M 21917M
Eli Lilly And LLY:US $ 15093.2M 3379M
Endo International Ordinary Shares ENDP:US $ 1409.21M 13.72M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Horizon Pharma HZNP:US $ 852.81M 78.97M
JAZZ PHA JAZZ:US $ 880.59M 128.5M
Lannett LCI:US $ 90.47M 6.66M
Marinus Pharmaceuticals MRNS:US $ 16.69M 0.57M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Perrigo Ordinary Shares PRGO:US $ 1984.5M 537.7M
Revance Therapeutics RVNC:US $ 58.25M 7.41M
Supernus Pharmaceuticals SUPN:US $ 283.45M 42.64M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
United Therapeutics UTHR:US $ 311.4M 9M
Xeris Pharmaceuticals Inc XERS:US $ 35.46M 8.04M